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Introduction {#add14871-sec-0009}
============

Individuals with alcohol use disorders (AUD) [1](#add14871-bib-0001){ref-type="ref"} account for a substantial part of the global disease burden caused by alcohol [2](#add14871-bib-0002){ref-type="ref"}, but fewer than 20% seek help within regular services [3](#add14871-bib-0003){ref-type="ref"}. Reasons for this vary. People may doubt that treatment will be effective, may think that they should be able to deal with the problem on their own and/or may deny having a problem altogether [4](#add14871-bib-0004){ref-type="ref"}. Importantly, AUD is severely stigmatized [5](#add14871-bib-0005){ref-type="ref"}, provoking more social rejection and negative emotions than other psychiatric conditions [6](#add14871-bib-0006){ref-type="ref"}. Internet interventions have been heralded as a way to attract some of those who hesitate seeking help within regular services. Aside from the obvious advantages of radically increasing access and eliminating geographical barriers, these interventions could hypothetically circumvent the stigma associated with physically visiting a clinic [7](#add14871-bib-0007){ref-type="ref"}.

Internet interventions can be conceptualized in two main ways: public health‐oriented low‐intensity internet interventions (LIII) characterized by brief treatment content and minimal or no therapist contact, and clinically oriented high‐intensity internet interventions (HIII) characterized by extensive treatment content akin to bibliotherapy and guidance by an active therapist [8](#add14871-bib-0008){ref-type="ref"}. The central argument for the low‐intensity concept has been its potential to radically increase treatment accessibility to the public at a small cost, while the main argument for the high‐intensity concept has been increase of patient access to manual‐based therapy while minimizing therapist time. Although internet interventions targeting alcohol problems are not new [9](#add14871-bib-0009){ref-type="ref"}, most have been LIII, typically single‐module 'brief interventions' [10](#add14871-bib-0010){ref-type="ref"} aimed at undiagnosed individuals with hazardous, rather than severe, drinking problems [11](#add14871-bib-0011){ref-type="ref"}. HIII have been extensively studied for depression and anxiety, and with meta‐analyses showing no differences in outcome between these interventions and face‐to‐face therapy [12](#add14871-bib-0012){ref-type="ref"} these interventions have been successfully implemented within psychiatric care in several countries [13](#add14871-bib-0013){ref-type="ref"}. However, studies investigating HIII for people with alcohol problems, especially among those with levels of severity similar to the population seen in clinics (i.e. individuals with AUD), are rare [11](#add14871-bib-0011){ref-type="ref"}. Two studies on alcohol problems directly compared a cognitive--behavioral therapy (CBT) internet program with and without therapist guidance [14](#add14871-bib-0014){ref-type="ref"}, [15](#add14871-bib-0015){ref-type="ref"}. In both, groups receiving therapist guidance reported significantly lower alcohol consumption at varying follow‐ups compared to the group not receiving therapist guidance, with small and medium differential effect sizes respectively. In a third study, a CBT internet program with therapist guidance was compared to a waiting‐list, rendering large between‐group effect sizes [16](#add14871-bib-0016){ref-type="ref"}. An important limitation of these studies is the absence of interview‐based diagnostic assessments, hampering generalizations to the AUD population [11](#add14871-bib-0011){ref-type="ref"}. Another limitation is that none of the studies investigated negative effects, a critical but neglected component when evaluating internet interventions [17](#add14871-bib-0017){ref-type="ref"}.

We conducted a randomized controlled trial among individuals with AUD to compare the effects of a HIII compared with a LIII and a waiting‐list (WL). We hypothesized that: participants in HIII would have reduced their alcohol consumption more than participants in LIII at a 6‐month follow‐up (primary end‐point); andparticipants in HIII and LIII would have reduced their alcohol consumption more than participants in WL at post‐treatment (treatment response).A secondary aim was to evaluate negative effects of the internet interventions.

Methods {#add14871-sec-0010}
=======

Design {#add14871-sec-0011}
------

We conducted a parallel, three‐group randomized, controlled trial with recruitment ongoing between January 2016 and February 2017 with follow‐ups at post‐treatment and 6 months post‐randomization. Participants were randomized without stratification by an independent third party, using an on‐line tool with a random number generator function (<http://www.randomizer.org>). A waiting‐list was added to contrast the two intervention groups. The effective randomization ratio was 7 : 7 : 2. Participants randomized to either of the interventions were blinded and were not informed about study hypotheses. The trial was prospectively registered (<https://clinicaltrials.gov/ct2/show/NCT02645721>). The Regional Ethics Vetting Board in Stockholm approved the trial (2015/2014--31; amendment 2016/295--32). All participants provided informed consent.

Participants {#add14871-sec-0012}
------------

Inclusion criteria were being aged ≥ 18 years, having a score of ≥ 14 (females)/ ≥ 16 (males) on the Alcohol Use Disorders Identification Test (AUDIT) [18](#add14871-bib-0018){ref-type="ref"}, a preceding week consumption of ≥ 11 (females)/≥ 14 (males) standard drinks of alcohol and an AUD, defined as two or more positive DSM‐5 criteria for AUD. Exclusion criteria were insufficient skills in Swedish language, reading/writing difficulties, concurrent psychological treatment, severe depression, acute suicidal ideation, illicit drug use problems and severe psychiatric comorbidity. Participants were recruited throughout Sweden through Google Adwords, Facebook and the Remente smartphone application (app). Interested individuals could register on the study website and complete an on‐line screening. Those potentially eligible underwent a structured psychiatric telephone interview with a clinical psychologist (69% of the interviews) or a clinical psychology master\'s level student under supervision from a clinical psychologist. All interviewers had undergone basic training in structured diagnostic interviewing. To establish an AUD diagnosis, the Structured Clinical Interview for DSM‐IV axis I disorders (SCID‐I) was used [19](#add14871-bib-0019){ref-type="ref"}, adapted to DSM‐5 criteria. Comorbid psychiatric disorders were assessed with the Mini International Neuropsychiatric Interview (MINI) [20](#add14871-bib-0020){ref-type="ref"}. Figure [1](#add14871-fig-0001){ref-type="fig"} shows participant flow throughout the trial.

![Study flow diagram. TLFB = time‐line follow‐back; AUDIT = Alcohol Use Disorders Identification Test; MADRS‐S = Montgomery--Åsberg Depression Rating Scale -- Self‐report; DUDIT = Drug Use Disorders Identification Test \[Colour figure can be viewed at <http://wileyonlinelibrary.com>\]](ADD-115-863-g001){#add14871-fig-0001}

Interventions {#add14871-sec-0013}
-------------

Both interventions were based on a CBT model of alcohol problems and delivered over 12 weeks. The platform was hosted on a server with encrypted traffic and authentication login function to guarantee participant confidentiality.

High‐intensity internet intervention {#add14871-sec-0014}
------------------------------------

In the HIII, the ePlus program was used (see [Supporting information](#add14871-supitem-0006){ref-type="supplementary-material"}, Appendix S7). This program has been previously evaluated in a pilot trial [21](#add14871-bib-0021){ref-type="ref"}, and is intended for use alongside approximately 15 minutes of therapist guidance per week via written messages. It consists of 13 modules with three to four pages of text and a video clip reflecting the theme. All participants had contact with a therapist using a secure built‐in message system. Participants were notified via SMS when they had a new message from the therapist. For each module, participants were instructed to complete homework assignments on work‐sheets, after which the therapist granted access to the next module. Therapists logged in two to three times a week to provide feedback on and encourage participants' work. Of the 10 therapists, six were clinical psychologists treating 75% of the participants and four were clinical psychology students at master\'s level, with basic clinical training and experience of providing therapy in milder cases. There was no randomization of participants at the therapist level. Clinical issues were discussed as needed with the senior author, a licensed clinical psychologist and psychotherapist. To ensure treatment integrity and adherence to protocol, the first author monitored messages sent by therapists, and provided weekly or biweekly supervision to therapists.

Low‐intensity internet intervention {#add14871-sec-0015}
-----------------------------------

In the LIII, the eChange program was used (see [Supporting information](#add14871-supitem-0007){ref-type="supplementary-material"}, Appendix S6). This program has been evaluated in several trials [14](#add14871-bib-0014){ref-type="ref"}, [15](#add14871-bib-0015){ref-type="ref"} and consists of nine modules and one to two pages of text; in this trial, an extra summary module was added to more accurately conform to the length of the ePlus program. Participants were instructed to complete homework assignments, and were consecutively granted access to new modules each week. Participants were notified via text messages when new modules were accessible on the intervention platform, but there was no therapist guidance or other contact with the research team. During weeks 8--11 participants received no new modules, but weekly text messages reminded participants to log in.

Participants in the WL condition had no contact with the research team during their waiting period except being requested to complete primary outcomes every 4 weeks, for which they received text reminders. Directly after the 12‐week waiting period, participants were offered the ePlus program with a choice of proactive, reactive or no therapist guidance.

Measures {#add14871-sec-0016}
--------

### Baseline measures {#add14871-sec-0017}

At screening, participants responded to a number of demographic and clinically relevant questions.

### Outcome measures {#add14871-sec-0018}

All participants completed outcome measures five times: at screening (all outcome measures), before treatment initiation (primary outcome only), at 4 and 8 weeks during treatment (primary outcome only) and after treatment; i.e. at 12 weeks (all outcome measures). In addition, the two intervention groups completed all outcome measures again at 6 months post‐randomization (primary end‐point).

### Primary outcome {#add14871-sec-0019}

At all assessment points, participants were asked about number of standard drinks (12 g of ethanol) consumed during each of the preceding 7 days according to the time‐line follow‐back method [22](#add14871-bib-0022){ref-type="ref"}. Two primary outcomes were considered: (1) total number of drinks and (2) number of heavy drinking days (HDD), defined as ≥ 5 (men) or ≥ 4 (women) standard drinks on a single day.

### Secondary outcomes {#add14871-sec-0020}

Three alcohol‐related questionnaires were used: the AUDIT [18](#add14871-bib-0018){ref-type="ref"} to assess changes in alcohol problems, the Alcohol Abstinence Self Efficacy Scale (AASES) [23](#add14871-bib-0023){ref-type="ref"} to assess changes in self‐efficacy and the Penn Alcohol Craving Scale (PACS) [24](#add14871-bib-0024){ref-type="ref"} to assess changes in cravings. The Montgomery--Åsberg Depression Rating Scale--self‐report (MADRS‐S) [25](#add14871-bib-0025){ref-type="ref"} was used to assess changes in depression, the Generalized Anxiety Disorder Scale (GAD‐7) was used to assess changes in anxiety [26](#add14871-bib-0026){ref-type="ref"} and Euroqol‐5D (EQ‐5D) [27](#add14871-bib-0027){ref-type="ref"} was used to assess changes in quality of life. The Drug Use Disorders Identification Test (DUDIT) [28](#add14871-bib-0028){ref-type="ref"} was used to assess illicit substance use.

### Treatment credibility, treatment satisfaction and other forms of help {#add14871-sec-0021}

The Treatment Credibility Scale (TCS) [29](#add14871-bib-0029){ref-type="ref"} was administered once during the third week of the intervention, and the Client Satisfaction Scale‐8 (CSQ‐8) [30](#add14871-bib-0030){ref-type="ref"} was administered post‐treatment, complemented with other evaluation questions. In addition, questions about whether participants had recently accessed any other forms of help for alcohol problems were administered at both follow‐ups.

### Negative effects {#add14871-sec-0022}

Negative effects were assessed halfway through treatment and immediately post‐treatment with the question: 'During the treatment, have you encountered any unwanted event that you feel was a result of the treatment or experienced any undesired effect of the treatment?'. Participants were then asked to describe the event/effect. Deterioration, defined as having a higher alcohol consumption (standard drinks/HDD) post‐treatment compared to screening, was also calculated.

### Analyses {#add14871-sec-0023}

The study was powered to detect a medium differential effect size in terms of standard drinks between intervention groups (Cohen\'s *d* = 0.5). Power calculations were based on results from previous trials of HIII [21](#add14871-bib-0021){ref-type="ref"} and LIII [15](#add14871-bib-0015){ref-type="ref"}. A sample size of 72 per group was deemed required for 80% power with a two‐sided 5% significance level. A large differential effect size was expected between HIII and the waiting‐list, and for this reason a small waiting‐list (≤ 25) was considered sufficient. All participants randomized were included in the outcome analysis according to intention‐to‐treat principles. Missing data were deemed missing at random with Little\'s MCAR test (*P* = 0.263). Multiple imputation with five imputed data sets (SPSS) was performed to manage missing data. Generalized estimating equations (GEE) with an unstructured working correlation matrix and a 3 (intervention) × 5 (pre‐treatment, mid‐treatment 1, mid‐treatment 2, post‐treatment, 6‐month follow‐up) design was used to assess intervention effects on primary outcomes with the screening measure included as a covariate. To evaluate effects on secondary outcomes, a 3 (intervention) × 3 (screening, post‐treatment, 6‐month follow‐up) was used. For primary outcomes, a negative binomial model with log‐link was used [31](#add14871-bib-0031){ref-type="ref"}, while a normal model was used for secondary outcomes. Planned two‐sided contrast tests were used to test between‐group differences. Analyses were performed using SPSS version 24 (IBM Corp., Armonk, NY, USA). In addition, Bayes factors (B) were calculated to assess strength of evidence of primary outcomes (drinks and HDD). A B of 3 or more indicates evidence for the alternative hypothesis (H1) over the null hypothesis (H0); a B below 1/3 indicates evidence for H0 over H1, while B between 1/3 and 3 indicates insensitive data. BH\[0, standard deviation (SD)\] refers to a Bayes factor in which the predictions of H1 are modeled as a half‐normal distribution with a peak at 0 (indicating no effect) and an SD equal to the expected effect size [32](#add14871-bib-0032){ref-type="ref"}. As with our power calculation, we expected a Cohen\'s *d* of 0.5 for our Bayes factor calculation when comparing HIII and LIII, suggesting a difference of 6.1 in number of drinks and 0.75 in number of HDD. Thus, we modeled H1 as a half‐normal with an SD of 6.1 and 0.75, respectively. Further, we used 0.8 as expected Cohen\'s *d* effect size when comparing HIII and WL, modeling H1 as half‐normal with an SD of 10.0 (drinks) and 1.12 (HDD), and a Cohen\'s *d* of 0.3 when comparing LIII and WL, modeling H1 as half‐normal with an SD of 3.9 (drinks) and 0.43 (HDD). To assess all Bayes factors, we used an on‐line calculator [33](#add14871-bib-0033){ref-type="ref"}.

Results {#add14871-sec-0024}
=======

Mean participant age was 52.9 years (SD = 10.7), and 49% were male. Seventy‐five per cent of participants had a severe AUD and 44% had a psychiatric comorbidity. There were no significant differences between groups on baseline characteristics (see Table [1](#add14871-tbl-0001){ref-type="table"}). At post‐treatment and at 6‐month follow‐up attrition was 13 and 22%, respectively, with no significant differences between the three groups at post‐treatment (χ^*2*^ = 1.67, *P* = 0.45) or between the two groups at 6‐month follow‐up (χ^*2*^ = 0.26, *P* = 0.61). Four participants (one in HIII and three in LIII) did not complete pre‐treatment measures, and subsequently made no attempts to access the treatment.

###### 

Baseline descriptive and clinical characteristics.

                                                                             High‐intensity (*n* = 72)   Low‐intensity (*n* = 71)   Waitlist (*n* = 23)   Total (*n* = 166)                                                                          
  -------------------------------------------------------------------------- --------------------------- -------------------------- --------------------- ------------------- ------ ------ ------ ------ ------------------------------------------ -------
  Age (years)                                                                51.9                        11.5                       53.7                  10.7                54.1   8.4    52.9   10.7   0.671                                      0.513
  Standard drinks                                                            34.2                        17.3                       33.8                  16.4                32.0   15.9   33.8   16.7   0.156                                      0.856
  Heavy drinking days                                                        4.00                        1.94                       3.99                  2.12                3.35   1.94   3.90   2.02   1.013                                      0.365
  AUDIT                                                                      23.2                        5.1                        23.9                  4.9                 22.1   4.5    23.3   4.9    1.217                                      0.299
  Self‐efficacy                                                              2.31                        0.66                       2.40                  0.73                2.61   0.47   2.39   0.67   1.792                                      0.170
  Craving                                                                    17.2                        4.7                        17.9                  5.2                 15.3   5.0    17.2   5.0    2.423                                      0.092
  Depression                                                                 17.2                        6.6                        15.9                  7.3                 16.4   7.3    16.5   7.0    0.631                                      0.534
  Anxiety                                                                    6.97                        4.17                       6.86                  4.96                6.13   3.76   6.81   4.46   0.316                                      0.729
  Quality of life                                                            0.50                        0.32                       0.51                  0.38                0.60   0.28   0.52   0.34   0.855                                      0.427
  Quality of life scale 1--100                                               59.9                        17.2                       63.7                  19.7                63.7   17.6   62.0   18.3   0.794                                      0.454
                                                                             *n*                         \%                         *n*                   \%                  *n*    \%     *n*    \%     χ[b](#add14871-note-0002){ref-type="fn"}   *P*
  Male                                                                       32                          44.4                       35                    49.3                14     60.9   81     48.8   1.895                                      0.388
  Highest educational level                                                                                                                                                                                                                          
  University                                                                 44                          61.1                       38                    53.5                12     52.2   94     56.6   2.184                                      0.702
  High school                                                                24                          33.3                       26                    36.6                10     43.5   60     36.1                                              
  Basic education                                                            4                           5.6                        7                     9.9                 1      4.3    12     7.2                                               
  Marital status                                                                                                                                                                                                                                     
  Married/partner                                                            50                          69.4                       53                    74.6                19     82.6   122    73.5   3.211                                      0.523
  Divorced/widowed                                                           8                           11.1                       10                    14.1                2      8.7    20     12.0                                              
  Single                                                                     14                          19.4                       8                     11.3                2      8.7    24     14.5                                              
  Occupational status[a](#add14871-note-0001){ref-type="fn"}                                                                                                                                                                                         
  100%                                                                       47                          65.3                       40                    56.3                14     60.9   101    60.8   4.285                                      0.831
  75%                                                                        6                           8.3                        4                     5.6                 2      8.7    12     7.2                                               
  50%                                                                        3                           4.2                        7                     9.9                 1      4.3    11     6.6                                               
  25%                                                                        5                           6.9                        6                     8.5                 3      13.0   14     8.4                                               
  0%                                                                         11                          15.3                       14                    19.7                3      13.0   28     16.9                                              
  Self‐perceived economic situation[b](#add14871-note-0002){ref-type="fn"}                                                                                                                                                                           
  Very good                                                                  12                          16.7                       15                    21.1                3      13.0   30     18.1   4.915                                      0.767
  Good                                                                       31                          43.1                       34                    47.9                9      39.1   74     44.6                                              
  Neither good nor bad                                                       18                          25.0                       15                    21.1                3      21.7   38     22.9                                              
  Bad                                                                        10                          13.9                       6                     8.5                 5      21.7   21     12.7                                              
  Very bad                                                                   1                           1.4                        1                     1.4                 1      4.3    3      1.8                                               
  Years with alcohol problems[c](#add14871-note-0003){ref-type="fn"}                                                                                                                                                                                 
  Less than 1 year                                                           1                           1.4                        0                     0.0                 0      0.0    1      0.6    8.086                                      0.425
  1--2 years                                                                 11                          15.3                       11                    15.5                1      4.3    23     13.9                                              
  3--5 years                                                                 20                          27.8                       16                    22.5                8      34.8   44     26.5                                              
  6--10 years                                                                20                          27.8                       13                    18.3                5      21.7   38     22.9                                              
  More than 10 years                                                         20                          27.8                       31                    43.7                9      39.1   60     36.1                                              
  Previously sought alcohol treatment (yes)                                  28                          38.9                       29                    40.8                12     52.2   69     41.6                                              
  Alcoholics Anonymous                                                       4                           6.1                        7                     10.4                5      23.8   16     9.6    1.293                                      0.524
  Psychotherapy                                                              7                           10.6                       10                    14.9                5      23.8   22     13.3                                              
  Pharmacological treatment                                                  16                          24.2                       13                    19.4                7      33.3   36     21.7                                              
  Alcohol use disorders (SCID‐IV)[d](#add14871-note-0004){ref-type="fn"}                                                                                                                                                                             
  Mild alcohol use disorder                                                  4                           5.6                        9                     12.9                0      0.0    13     7.8    6.145                                      0.189
  Moderate alcohol use disorder                                              15                          20.8                       10                    14.3                3      13.0   28     16.9                                              
  Severe alcohol use disorder                                                53                          73.6                       51                    72.9                20     87.0   124    74.7                                              
  Any psychiatric comorbidity (MINI)                                         30                          41.7                       31                    44.3                12     52.2   73     44.2   0.780                                      0.677
  Depression                                                                 19                          26.4                       14                    20.0                9      39.1   42     25.5   3.398                                      0.183
  Agoraphobia                                                                9                           12.5                       10                    14.3                3      13.0   22     13.3   0.100                                      0.951
  Generalized anxiety disorder                                               6                           8.3                        7                     10.0                4      17.4   17     10.3   1.560                                      0.458
  Social phobia                                                              5                           6.9                        6                     8.6                 3      13.0   14     8.5    0.836                                      0.658
  Other                                                                      4                           5.6                        9                     12.7                1      4.3    14     8.4    2.924                                      0.232

Occupational status = 'To what degree are you presently occupied with work, studies or self‐employed?'

Self‐perceived economic situation = 'How would you describe your current economic situation?'

Years with alcohol problems = 'For about how long would you say that you have had alcohol problems?'

Diagnostic interview information (SCID and MINI) collected from one participant in the low‐intensity group was lost. Thus, diagnostic information about the low‐intensity group only consists of 70 participants. AUDIT: = Alcohol Use Disorders Identification Test; SCID = Structured Clinical Interview for DSM‐IV axis I disorders; MINI = Mini International Neuropsychiatric Interview.

Adherence, treatment credibility and therapist--participant interaction {#add14871-sec-0025}
-----------------------------------------------------------------------

At post‐treatment, participants in HIII had completed 8.4 (SD = 3.9; 64.6%) of 13 module work‐sheets, while participants in LIII had completed 5.9 (SD = 2.8; 65.5%) of nine module work‐sheets. There were no significant differences between groups in credibility ratings during the third week of intervention (HIII = 34.2; LIII = 33.5; *t* = 0.01, *P* = 0.617). The average number of messages sent from therapists to participants in HIII was 15.4 (SD = 6.8). The corresponding number of messages sent from participants to therapists was 13.1 (SD = 8.3). Therapists in HIII spent 13.5 (SD = 8.1) minutes a week per participant.

Primary outcomes {#add14871-sec-0026}
----------------

To control for chance imbalances on demographic and clinical characteristics in the three conditions, we tentatively added each characteristic as a covariate to the treatment model. None of these were significant and none were thus added in the final model (see Supporting information, [Appendix S1](#add14871-supitem-0001){ref-type="supplementary-material"}).

At the 6‐month follow‐up, there were no significant differences between HIII and LIII either in number of standard drinks \[HIII = 16.6 versus LIII = 14.5, *t* ~(141)~ = 0.986, *P* = 0.326, *d* = −0.17, 95% CI: −0.50 − 0.16, BH(0, 6.1) = 0.16\] or in number of HDD \[HIII = 1.77 versus LIII = 1.66, *t* ~(141)~ = 0.419, *P* = 0.676, *d* = −0.07, 95% CI: −0.40 − 0.26, BH(0, 0.75) = 0.23\] (see Table [2](#add14871-tbl-0002){ref-type="table"}). At the post‐treatment follow‐up, participants in HIII had a significantly greater reduction compared to WL both in number of standard drinks \[HIII = 10.9 versus WL = 20.6, *t* ~(93)~ = 3.209, *P* = 0.002; *d* = 0.78, BH(0, 10.0) = 67.86\] and in number of HDD per week \[HIII = 1.22 versus WL = 2.51, *t* ~(93)~ = 3.867, *P* = 0.0002; *d* = 0.92, BH(0, 1.12) = 456.16\] and so did participants in LIII \[drinks: LIII = 14.4 versus WL = 20.6, *t* ~(92)~ = 2.012, *P* = 0.047; *d* = 0.48, BH(0, 3.9) = 4.00\], HDD: (LIII = 1.69 versus WL = 2.51, *t* ~(92)~ = 2.334, *P* = 0.022; *d* = 0.57, BH(0, 0.43) = 7.47\]. There was no significant difference between HIII and LIII in number of standard drinks \[HIII = 10.9 versus LIII = 14.4, *t* ~(141)~ = 1.704, *P* = 0.091, *d* = 0.29, BH(0, 6.1) = 2.14\], but participants in HIII had significantly fewer HDD than participants in LIII \[HIII = 1.22 versus LIII = 1.69, *t* ~(141)~ = 2.003, *P* = 0.047; *d* = 0.34, BH(0, 0.75) = 3.62\] ,[2](#add14871-tbl-0002){ref-type="table"}

###### 

Primary and secondary outcomes across time × group**.**

                                      High‐intensity   Low‐intensity   Wait list   Cohen\'s *d*                                                                                                                 
  ----------------------------------- ---------------- --------------- ----------- -------------- ------ ------ ---------------------------------------------- ------------------------------------------------ ----------------------------------------------
  Standard drinks                                                                                                                                                                                               
  Pre‐treatment                       22.3             1.4             22.9        1.6            22.6   2.9                                                                                                    
  Mid‐treatment 1                     16.6             1.5             17.3        1.4            27.0   3.1                                                                                                    
  Mid‐treatment 2                     13.1             1.3             15.9        1.5            26.5   2.8                                                                                                    
  Post‐treatment                      10.9             1.4             14.4        1.5            20.6   2.7    0.29                                           0.78[\*](#add14871-note-0006){ref-type="fn"}     0.48[\*](#add14871-note-0006){ref-type="fn"}
  6‐month follow‐up                   16.6             1.5             14.5        1.5            NA     NA     0.17                                           --                                               --
  Heavy drinking days                                                                                                                                                                                           
  Pre‐treatment                       2.57             0.14            2.51        0.19           2.43   0.32                                                                                                   
  Mid‐treatment 1                     1.81             0.17            1.98        0.18           2.94   0.36                                                                                                   
  Mid‐treatment 2                     1.59             0.17            1.79        0.19           3.17   0.36                                                                                                   
  Post‐treatment                      1.22             0.16            1.69        0.17           2.51   0.30   0.34[\*](#add14871-note-0006){ref-type="fn"}   0.92[\*\*](#add14871-note-0007){ref-type="fn"}   0.57[\*](#add14871-note-0006){ref-type="fn"}
  6‐month follow‐up                   1.77             0.17            1.66        0.19           NA     NA     0.07                                           --                                               --
  AUDIT                                                                                                                                                                                                         
  Post‐treatment                      15.3             0.8             16.5        0.9            18.6   1.2    0.17                                           0.51[\*](#add14871-note-0006){ref-type="fn"}     0.32
  6‐month follow‐up                   15.5             0.9             14.4        1.0            NA     NA     0.14                                           --                                               --
  Self‐efficacy (AASES)                                                                                                                                                                                         
  Post‐treatment                      3.06             0.10            3.12        0.11           2.96   0.19   0.07                                           0.12                                             0.17
  6‐month follow‐up                   3.15             0.11            3.34        0.11           NA     NA     0.20                                           --                                               --
  Craving (PACS)                                                                                                                                                                                                
  Post‐treatment                      10.8             0.7             11.5        0.8            11.8   1.3    0.11                                           0.17                                             0.05
  6‐month follow‐up                   11.2             0.7             10.3        0.8            NA     NA     0.14                                           --                                               --
  Depression (MADRS)                                                                                                                                                                                            
  Post‐treatment                      9.2              0.9             9.6         0.9            13.2   1.7    0.05                                           0.49[\*](#add14871-note-0006){ref-type="fn"}     0.45
  6‐month follow‐up                   10.5             1.0             9.8         0.9            NA     NA     0.09                                           --                                               --
  Anxiety (GAD‐7)                                                                                                                                                                                               
  Post‐treatment                      4.53             0.45            4.14        0.52           5.47   0.89   0.09                                           0.23                                             0.31
  6‐month follow‐up                   4.67             0.60            3.95        0.50           NA     NA     0.16                                           --                                               --
  Quality of life (EQ 5D)                                                                                                                                                                                       
  Post‐treatment                      0.60             0.04            0.64        0.05           0.53   0.07   0.09                                           0.21                                             0.28
  6‐month follow‐up                   0.56             0.05            0.65        0.05           NA     NA     0.20                                           --                                               --
  Quality of life scale (EQ 5D‐VAS)                                                                                                                                                                             
  Post‐treatment                      68.1             2.0             73.6        2.0            69.9   2.7    0.37                                           0.12                                             0.25
  6‐month follow‐up                   66.9             2.2             72.4        2.1            NA     NA     0.30                                           --                                               --

HIII = high‐intensity internet intervention, LIII = low‐intensity internet intervention; WL = waiting‐list; AUDIT = Alcohol Use Disorders Identification Test; MADRS = Montgomery--Åsberg Depression Rating Scale; GAD‐7 = Generalized Anxiety Disorder Scale; PACS = Penn Alcohol Craving Scale; AASES = Alcohol Abstinence Self Efficacy Scale; NA = not available; SE = standard error.

≤ 0.05,

≤ 0.01.

As we noted a sharp decrease in alcohol consumption between screening and pre‐treatment, we assessed these within‐group changes; they were significant for all three groups (*P* = ≤ 0.01). Measures of alcohol consumption before, during and after treatment in the three groups are shown in Fig. [2](#add14871-fig-0002){ref-type="fig"}.

![Number of standard drinks consumed (panel 1) and number of heavy drinking days (panel 2) during preceding calendar week before, during, after treatment and at 6‐month follow‐up](ADD-115-863-g002){#add14871-fig-0002}

We explored AUD severity, psychiatric comorbidity and having accessed other forms of help as predictors of alcohol outcomes. None of these factors affected outcomes significantly (see Supporting information, [Appendices S2--S4](#add14871-supitem-0001){ref-type="supplementary-material"}).

Secondary outcomes {#add14871-sec-0027}
------------------

At post‐treatment, participants in HIII had reduced their AUDIT and MADRS‐S scores significantly compared to WL (AUDIT: HIII = 15.3 versus WL = 18.6, *t* ~(93)~ = 2.249, *P* = 0.027; *d* = 0.51; MADRS‐S: HIII 9.2 versus WL = 13.2, *t* ~(93)~ = 2.06, *P* = 0.042; *d* = 0.49), but there was no significant difference between HIII and LIII or between LIII and WL in these two measures or in any other measures. At 6‐month follow‐up, there were no significant differences between intervention groups. At post‐treatment, three participants, two in HIII and one in LIII, had positive DUDIT scores, with total scores of ≤ 6. At 6‐month follow‐up, six participants, five in HIII and one in LIII, had DUDIT scores over 0 (range = 19).

Treatment satisfaction and other forms of help {#add14871-sec-0028}
----------------------------------------------

Participants in HIII were significantly more satisfied than participants in LIII according to their CSQ‐8 total score (HIII = 24.8 versus LIII = 22.0, *t* ~(121)~ = 3.51, *P* = 0.001), see Table [3](#add14871-tbl-0003){ref-type="table"}. Participants were also asked additional questions; see Supporting information, [Appendix S5](#add14871-supitem-0001){ref-type="supplementary-material"}.

###### 

Client satisfaction questionnaire.

                                                                                                                                         High‐intensity *n* = 63   Low‐intensity *n* = 60                        
  --------------------------------------------------------------------------------------------- ---------------------------------------- ------------------------- ------------------------ ---- ------ -------- -------
  1\. How would you rate the quality of the service you received?                               Good/excellent                           51                        80.9                     33   55.0   9.559    0.002
  2\. Did you get the kind of service that you wanted?                                          Yes, generally/yes, definitely           44                        69.8                     28   46.7   6.800    0.009
  3\. To what extent has our program met your needs?                                            All/most of my needs have been met       43                        68.3                     39   65.0   0.146    0.702
  4\. If a friend were in need of similar help, would you recommend our program to him/her?     Yes, generally/yes, definitely           57                        90.4                     48   80.0   2.700    0.100
  5\. How satisfied are you with the amount of help that you received?                          Mostly/very satisfied                    59                        93.7                     43   71.7   10.490   0.001
  6\. Have the services you received helped you to deal more effectively with your problems?    Yes, they helped somewhat/a great deal   60                        95.2                     47   78.3   7.761    0.005
  7\. In an overall, general sense, how satisfied are you with the service you have received?   Mostly/very satisfied                    55                        87.3                     41   68.3   6.454    0.011
  8\. If you were to seek help again, would you come back to our program?                       Yes, I think so/yes, definitely          48                        76.2                     38   63.3   2.415    0.120

At post‐treatment, 10 (15.8%) of participants in HIII and 12 (16.6%) of participants in LIII reported having received some other form of help. At 6‐month follow‐up, 14 (24.5%) of participants in HIII and 15 (27.7%) of participants in LIII reported having received some other form of help (details provided in Supporting information, [Appendix S3](#add14871-supitem-0001){ref-type="supplementary-material"}). There were no significant differences between groups.

Negative effects and deterioration {#add14871-sec-0029}
----------------------------------

Halfway through the program, 10 (13.8%) participants in HIII and 14 (19.7%) in LIII reported a negative effect, while at post‐treatment, six (9.5%) participants in HIII and five (8.3%) in LIII reported a negative effect. When analyzing content of the comments, four distinct categories emerged: first, some participants reported experiencing alcohol‐related changes during treatment, such as increased craving, having more intense thoughts about alcohol or even an increase in alcohol consumption. Secondly, some participants reported negative social consequences, such as being questioned by an intimate partner or no longer being able to spend time with friends who drink. Thirdly, some participants reported experiencing feelings of distress; for example, stress about the intervention or feeling depressed due to the intervention constantly reminding them of their alcohol problems. Fourthly, some participants reported somatic, possibly abstinence‐related, symptoms such as headache and sleeping problems (some, but not all, were abstinent at the time of reporting this). Regarding deterioration, two (3.2%) participants in HIII, three (4.9%) participants in LIII and four (18%) participants in WL showed a deterioration in relation to standard drinks, while one participant (1.6%) in HIII, six participants (10%) in LIII and four (18%) participants in WL showed deterioration in relation to HDD.

Discussion {#add14871-sec-0030}
==========

The high‐intensity internet intervention did not result in significantly greater alcohol reductions at the 6‐month follow‐up compared to the low‐intensity internet intervention. Both the high‐ and low‐intensity interventions were significantly more effective in reducing alcohol consumption than the waiting‐list. Adherence was high in both intervention groups, while few negative effects were reported and deterioration was rare. Although we found a significant difference with a small effect size between interventions in HDD at the post‐treatment follow‐up (*P* = 0.047), this finding should be interpreted with caution, as we did not correct for multiple testing. At the 6‐month follow‐up, mean consumption in the high‐intensity internet intervention had increased since last follow‐up, in contrast to the low‐intensity internet intervention where mean consumption had remained at virtually the same level. A speculation is that therapist guidance functioned as a temporary motivation booster, which for some participants resulted in relapse when the guidance eventually ended. The low‐intensity group, in contrast, did not experience the ending of any guidance as they had to guide themselves through the intervention. Most AUD patients relapse within the first year [34](#add14871-bib-0034){ref-type="ref"}, and continuing care, i.e. regular check‐ups on patients after treatment, has a demonstrable effect on alcohol consumption [35](#add14871-bib-0035){ref-type="ref"}. A possible way to extend the short‐term effects of the high‐intensity internet intervention would be to provide therapist check‐ups after treatment has ended. Although differences in outcomes were small or non‐significant, participants in HIII were significantly more satisfied with the treatment, implying that therapist‐guided interventions may be more appreciated by users than unguided ones.

Our results differ from findings in previous studies where guided internet interventions have been found more effective than unguided internet interventions [14](#add14871-bib-0014){ref-type="ref"}, [15](#add14871-bib-0015){ref-type="ref"}. Notably, differences between a guided and an unguided intervention were larger in a previous pilot trial [15](#add14871-bib-0015){ref-type="ref"}, mainly because the unguided group in the present trial reduced their alcohol consumption to a greater degree than the unguided group in the previous trial, despite the two groups receiving the same program (eChange). A probable explanation is that the comprehensive inclusion process in this study (i.e. use of diagnostic interview) increased motivation among those randomized to the low‐intensity intervention. The phenomenon of assessment reactivity [36](#add14871-bib-0036){ref-type="ref"} is well documented, and diagnostic assessment has been associated with pre‐treatment change [37](#add14871-bib-0037){ref-type="ref"}. This explanation is corroborated by evaluation questions confirming that participants perceived the diagnostic interview as therapeutic (see Supporting information, [Appendix S5](#add14871-supitem-0001){ref-type="supplementary-material"}. Thus, an unexpected, clinically relevant finding is that assessment‐related human contact may augment the effects of a low‐intensity internet intervention. Further, attrition in the unguided group was surprisingly low. In a previous trial comparing guided to unguided internet interventions, we had major differential attrition [15](#add14871-bib-0015){ref-type="ref"}. However, we found no differential attrition in this trial. A possible explanation is that the diagnostic interview contributed positively to participants' engagement and adherence in the trial, including completion of follow‐up assessments.

This is the first time, to our knowledge, that systematic diagnostic assessment was used as an inclusion criterion in an alcohol trial where a therapist‐guided internet intervention is tested against an unguided internet intervention. Although some internet intervention trials have included diagnosed participants, these studies have tended to also include users of cannabis [38](#add14871-bib-0038){ref-type="ref"} and other substances [39](#add14871-bib-0039){ref-type="ref"}. This study thus makes generalizations to the clinical population more valid than previous studies [11](#add14871-bib-0011){ref-type="ref"}. The low attrition implies high internal validity [40](#add14871-bib-0040){ref-type="ref"}. Another contribution to the literature is our exploration of negative effects. Prevalence of negative effects was similar to other studies [17](#add14871-bib-0017){ref-type="ref"} indicating that internet interventions are safe for people with AUD (although negative reactions may occur and should be monitored). Almost half of participants had psychiatric comorbidity, with depression affecting more than 25% of participants. AUD and depression commonly occur, and although international guidelines suggest addressing both conditions in integrated, dual‐focus interventions to improve both alcohol and depression outcomes, a recent review indicates that evidence for this is sparse [41](#add14871-bib-0041){ref-type="ref"}. Research into how internet interventions might best be tailored to fit different psychiatric profiles could contribute significantly to identifying necessary adaptations of future clinical practice.

This study has limitations. First, participants were recruited by self‐referral and may have had high initial motivation to change. Secondly, the diagnostic assessment interview may have further sorted out less motivated individuals. Thirdly, all data collection was based on self‐report and may thus reflect recall bias and/or social desirability. Although reliance on self‐report measures is standard in alcohol treatment trials, corroboration with objective ways of measuring alcohol consumption (i.e. blood tests) would strengthen future evaluations. Lastly, participants in the waiting‐list first decreased their alcohol consumption after the interview, but then increased it again after having been randomized to the waiting‐list. This pattern may thus partly reflect disappointment after participants realized that they had been randomized to a waiting‐list instead of a natural progression.

High‐ and low‐intensity internet interventions seem effective, acceptable and safe and may have potential as alternatives to traditional treatment forms for people with AUD who, for varying reasons, are reluctant or unable to visit a clinic. Further research is needed to elucidate the differential contributions of high‐ versus low‐intensity internet interventions to recovery from AUD. The field is mature for trials conducted in clinical settings.
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